Showcasing Novel Liver-Targeted Mitochondrial Protonophores Approach for the Treatment of Obesity and Diabetes
Time: 1:15 pm
day: Conference Day Two
Details:
- Leveraging mitochondrial uncoupling with synthetic protonophores as a clinically validated mechanism for weight loss
- Overcoming hyperthermia due to uncontrolled systemic uncoupling which has limited clinical development of synthetic protonophores
- Outlining pioneering efforts from OrsoBio which have created a portfolio of synthetic protonophores that demonstrate enhanced therapeutic margins owing to their livertargeted pharmacology
